Editorial: Refining patterns of left ventricular hypertrophy using cardiac MRI: "Brother, can you spare a paradigm?"

Circulation: Cardiovascular Imaging

Volumn 3, Issue 2, 2010, Pages 129-131

  Chinali, Marcello ^a   Aurigemma, Gerard P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Diagnosis; Echocardiography; Editorials; Hypertension; Magnetic resonance imaging; Myocardium

Indexed keywords

ACCURACY; AFRICAN AMERICAN; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; EDITORIAL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART STROKE VOLUME; HEART WORK; HUMAN; HYPERTENSION; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; VOLUMETRY; ADAPTATION; CLASSIFICATION; METHODOLOGY; NOTE; PATHOPHYSIOLOGY; PHENOTYPE;

ADAPTATION, PHYSIOLOGICAL; ECHOCARDIOGRAPHY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; PHENOTYPE;

EID: 77951904476     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.110.944959     Document Type: Editorial

References (37)

1. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995; 26: 195-202.
2. Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993; 88: 1444-1455.
3. Levy D, Garrison RJ, Savane DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322: 1561-1566.
4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114: 345-352.
5. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977; 55: 613-618.
6. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57: 450-458.
7. Devereux RB, Dahlöf B, Gerdts E, Boman K, Nieminen MS, Papadem-etriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation. 2004; 110: 1456-1462.
8. Devereux RB, Pini R, Aurigemma GP, Roman MJ. Measurement of left ventricular mass: methodology and expertise. J Hypertens. 1997; 15: 801-809.
9. Mor-Avi V, Sugeng L, Weinert L, MacEneaney P, Caiani EG, Koch R, Salgo IS, Lang RM. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation. 2004; 110: 1814-1818.
10. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008; 52: 2148-2155.
11. Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Luka-shevich V, Cherif Papst C, Smith BA, Dahlöf B. Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators: effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation. 2009; 119: 530-537.
12. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A four-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas Heart Study. Circ Cardiovasc Imaging. 2010; 3: 164-171.
13. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992; 19: 1550-1558.
14. Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 1960; 5: 370-382.
15. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, Williams DW, Henderson WG. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol. 1994; 24: 1492-1498.
16. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Mantero F, Fallo F. Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol. 2003; 41: 2275-2279.
17. Kuch B, von Scheidt W, Peter W, Doring A, Piehlmeier W, Landgraf R, Meisinger C. Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study. Diabetes Care. 2007; 30: 946-952.
18. Ries M, Gupta S, Moore DF, Sachdev V, Quirk JM, Murray GH, Rosing DR, Robinson C, Schaefer E, Gal E. Pediatric Fabry disease. Pediatrics. 2005; 115: e344-e355.
19. Duncan AI, Lowe BS, Garcia MJ, Xu M, Gillinov AM, Mihaljevic T, Koch CG. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg. 2008; 85: 2030-2039.
20. de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective. J Am Soc Nephrol. 2003; 14: 2421-2427.
21. Matteucci MC, Wühl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F; ESCAPE Trial Group. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol. 2006; 17: 218-226.
22. Amin RS, Kimball TR, Bean JA, Jeffries JL, Willging JP, Cotton RT, Witt SA, Glascock BJ, Daniels SR. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med. 2002; 165: 1395-1399.
23. Mansoor A, Golub ET, Dehovitz J, Anastos K, Kaplan RC, Lazar JM. The association of HIV infection with left ventricular mass/hypertrophy. AIDS Res Hum Retroviruses. 2009; 25: 475-481.
24. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004; 43: 731-738.
25. Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. J Am Coll Cardiol Cardiovasc Imaging. 2008; 1: 582-591.
26. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlöf B, Devereux RB. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008; 9: 809-815.
27. Sadler DB, Aurigemma GP, Williams DW, Reda DJ, Materson BJ, Gottdiener JS. Systolic function in hypertensive men with concentric remodeling. Hypertension. 1997; 30: 777-781.
28. Gaasch WH, Delorey DE, St John Sutton MG, Zile MR. Patterns of structural and functional remodeling of the left ventricle in chronic heart failure. Am J Cardiol. 2009; 102: 459-462.
29. Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M, Welty TK, Lee ET, Fabsitz RR, Howard BV. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol. 2001; 87: 1260-1265.
30. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, Resnick HE, Lee ET, Best LG, de Simone G. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol. 2004; 93: 40-44.
31. Eng C, Zhao M, Factor SM, Sonnenblick EH. Post-ischaemic cardiac dilatation and remodelling: reperfusion injury of the interstitium. Eur Heart J. 1993; 14 (Suppl A) : 27-32.
32. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997; 336: 1350-1355.
33. Chinali M, Aurigemma GP, Gaasch WH, Gerdts E, Okin PM, Wachtell K, Kjeldsen SF, Julius S, de Simone G, Devereux RB. Cardiac Remodeling and Diastolic Dysfunction Precede non MI-Related Heart Failure in High-Risk Hypertensive Patients: The LIFE Echo Substudy [abstract]. American College of Cardiology, 59th Annual Scientific Session, 2010: Atlanta, GA.
34. Schmitt JP, Semsarian C, Arad M, Gannon J, Ahmad F, Duffy C, Lee RT, Seidman CE, Seidman JG. Consequences of pressure overload on sar-comere protein mutation-induced hypertrophic cardiomyopathy. Circulation. 2003; 108: 1133-1138.
35. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens. 1998; 16: 1031-1041.
36. Salvetti M, Muiesan ML, Paini A, Monteduro C, Bonzi B, Galbassini G, Belottivc E, Movilli E, Cancarini G, Agabiti-Rosei E. Myocardial ultrasound tissue characterization in patients with chronic renal failure. J Am Soc Nephrol. 2007; 18: 1953-1958.
37. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purka-yastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP; Valsartan In Diastolic Dysfunction (VALIDD) Investigators: Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet. 2007; 369: 2079-2087.